EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 79 filers reported holding EIDOS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,195,000 | +237.6% | 9,072 | +29.4% | 0.00% | – |
| Q3 2020 | $354,000 | +19.2% | 7,010 | +12.2% | 0.00% | – |
| Q2 2020 | $297,000 | +53.1% | 6,245 | +57.4% | 0.00% | – |
| Q1 2020 | $194,000 | -26.0% | 3,967 | -13.5% | 0.00% | – |
| Q4 2019 | $262,000 | +138.2% | 4,585 | +48.1% | 0.00% | – |
| Q3 2019 | $110,000 | -26.2% | 3,095 | -36.6% | 0.00% | – |
| Q2 2019 | $149,000 | -65.2% | 4,883 | -73.4% | 0.00% | – |
| Q1 2019 | $428,000 | +415.7% | 18,362 | +202.1% | 0.00% | – |
| Q4 2018 | $83,000 | -73.0% | 6,079 | -80.3% | 0.00% | – |
| Q3 2018 | $307,000 | – | 30,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|